Transient PNP

CA: 2

RF: 0

CA: 15

CA: 22

(=13%)

AAD: 0

CA: 2.1%

RF: 0

CA: 4

LB: 3

nr

CA: 2

RF: 0

CA: 1

RF: 0

Chronic PNP

CA: 0

RF: 0

CA: 0

CA: 4

AAD: 0

CA: 1.0%

RF: 0.3%

CA: 0

LB: 0

nr

CA: 0

RF: 0

CA: 0

RF: 0

PVS

CA: 0

RF: 0

CA: 2

CA: 5

AAD: 0

CA: 0

RF: 0

CA: 0

LB: 0

CA: 0

RF: 0

CA: 0

RF: 0

PV-narrowing < 50%^#)

CA: 1

RF: 5

CA: 0

RF: 0

Atria-oesophag fistula

CA: 0

RF: 0

CA: 0

CA: 0

AAD: 0

CA: 0

RF: 0

CA: 0

LB: 0

CA: 0

RF: 0

CA: 0

RF: 0

CA: 0

RF: 0

Vascular complication + major bleedings

CA: 0

RF: 0

CA: 0

CA: 5

AAD: 1

CA: 2.7%

RF: 4.6%

CA: 2

LB: 4

CA: 0

RF: 0

CA: 2

RF: 1

CA: 0^***)

RF: 1

Follow-up

AF-freedom

12 mo after index-ablation

AF freedom

30 mo after index-ablation

12 mo free from chronic treatment failure

AF freedom

12 mo after single index ablation

AF freedom

90 - 365 days after index ablation

AF freedom 3 - 12 mo

after index ablation

AF freedom

3 - 12 mo

After index ablation

AF freedom

3 - 12 mo

after index

ablation

CA:

PAF group:

77%

Persistent AF group: 48%

RF:

PAF group:

72% free from recurrence

CA: 61.6%

CA: 69.9%

AAD: 7.3%

Cross-over

AAD → CA:

79%

CA: 54.2%

RF: 54.4%

CA: 63%

RF: 73%

Intention to treat:

CA: 43%

RF: 58%

On treatment:

CA: 38%

RF: 53%

CA: 46%

RF: 34%

CA: 48%

RF: 68%

Repeat ablation during follow-up:

CA: 24%

RF: 0%